The token linked to a decentralized exchange (DEX) operating on Solana (SOL) has surged by over 95% this week, driven by substantial growth in the network. Raydium (RAY) functions as…
Cryptocurrencies had an impressive week, riding a wave spurred by a rising stock market and declining interest rates. This turnaround reflects a shift from the factors that previously drove crypto…
Solana (SOL) has surged past XRP to claim the fifth spot among cryptocurrencies, marking a significant milestone with its market cap soaring to a 20-month peak of $33.7 billion, according…
The cryptocurrency market kept its bullish momentum rolling on Wednesday, witnessing upward movements in most major cryptocurrencies. While there wasn’t any groundbreaking news shaping the industry, little snippets of developments…
Mags, a cryptocurrency trader and analyst known on X (formerly Twitter), foresees INJ, Injective’s native crypto, hitting the $50 milestone soon. He initially predicted this when INJ attempted to break…
Today, the markets are experiencing a modest bullish trend, with the global market cap slightly below its previous 24-hour mark at 3.4%, totaling $1.61 trillion. The fear and greed index…
The digital asset market witnessed a strong rebound today, boosting investor confidence amid recent volatility driven by regulatory concerns and broader economic factors. The market’s resurgence hints at a potential…
Bitcoin, after experiencing a downturn and hitting approximately $40,500, has finally seen a significant upward surge, surpassing the $43,000 mark today. Altcoins have followed suit, with SOL jumping above $70…
In a remarkable turn, Astar has surged by 48.07% in the last day, presently trading at $0.112. This surge has captivated the crypto community, urging a deeper investigation into the…
Social media buzz around Injective Protocol (INJ) has surged according to AlphaScan’s data on December 12, with a notable increase in both daily and weekly mentions. INJ now stands as…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More